Huaihe Hospital of Henan University Researchers Have Published New Study Findings on Non-Small Cell Lung Cancer (Cytotoxicity and inhibitory potential of CUDC-101 in non-small cell lung cancer cells with rare EGFR L861Q mutation).

Researchers from Huaihe Hospital of Henan University in China conducted a study on non-small cell lung cancer, focusing on the rare EGFR L861Q mutation. They found that CUDC-101 showed promising anti-tumor effects on cell lines with this mutation, inhibiting proliferation and promoting apoptosis. The study suggests that CUDC-101 could be a potential treatment option for NSCLC patients with this specific mutation. The research was published in Current Research in Toxicology by Elsevier. [Extracted from the article]